Sponsor:
Canadian Medical and Surgical Knowledge Translation Research Group
Code:
NCT05870462
Conditions
Atherosclerosis
Cardiovascular Diseases
Diabetes Mellitus, Type 2
Obesity
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Semaglutide Pen Injector
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-17. This information was provided to ClinicalTrials.gov by Canadian Medical and Surgical Knowledge Translation Research Group on 2023-07-25.